Sara H. Hazem

The JAK inhibitor ruxolitinib abrogates immune hepatitis instigated by concanavalin A in mice

M. E. Shaker, M. El-Mesery, O. Hendawy, 2021, International immunopharmacology.

Comparison of lactate and &bgr;‐hydroxybutyrate in the treatment of concanavalin‐A induced hepatitis

M. Hamed, Sara H. Hazem, M. Saad, 2018, International immunopharmacology.

Inhibition of the JAK/STAT pathway by ruxolitinib ameliorates thioacetamide-induced hepatotoxicity.

M. E. Shaker, S. A. Ashamallah, Sara H. Hazem, 2016, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

The novel Janus kinase inhibitor ruxolitinib confers protection against carbon tetrachloride-induced hepatotoxicity via multiple mechanisms.

M. E. Shaker, S. A. Ashamallah, Sara H. Hazem, 2014, Chemico-biological interactions.

Inhibition of Bruton tyrosine kinase by acalabrutinib dampens lipopolysaccharide/galactosamine-induced hepatic damage.

M. M. Al-Sanea, M. E. Shaker, M. El-Mesery, 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

The NEDD8-activating enzyme inhibition with MLN4924 sensitizes human cancer cells of different origins to apoptosis and necroptosis.

M. E. Shaker, M. El-Mesery, Sara H. Hazem, 2020, Archives of biochemistry and biophysics.

Emerging roles of tyrosine kinases in hepatic inflammatory diseases and therapeutic opportunities.

M. E. Shaker, M. El-Mesery, Sara H. Hazem, 2023, International immunopharmacology.

Escin suppresses immune cell infiltration and selectively modulates Nrf2/HO-1, TNF-α/JNK, and IL-22/STAT3 signaling pathways in concanavalin A-induced autoimmune hepatitis in mice

Sara H. Hazem, M. Elshal, Mahmoud Elshal, 2022, Inflammopharmacology.

Vinpocetine and Lactobacillus improve fatty liver in rats via modulating the oxidative stress, inflammation, adiponectin and gut microbiome.

A. Shata, M. E. Shaker, Sara H. Hazem, 2023, Life sciences.

STA9090 as a Potential Therapeutic Agent for Liver Fibrosis by Modulating the HSP90/TβRII/Proteasome Interplay: Novel Insights from In Vitro and In Vivo Investigations

Osama A. Mohammed, Sameh Saber, Sara H. Hazem, 2023, Pharmaceuticals.

Mitigation of acetaminophen-induced liver toxicity by the novel phosphatidylinositol 3-kinase inhibitor alpelisib

M. El-Mesery, Sara H. Hazem, H. Gomaa, 2023, Frontiers in pharmacology.

Roflumilast extenuates inflammation and oxidative stress in cadmium-induced hepatic and testicular injury in rats.

G. Suddek, Sara H. Hazem, Maha H. Sharawy, 2023, International immunopharmacology.